51 results
Page 2 of 3
PRE 14A
l3zm7pby1kma1vag5at
11 Apr 23
Preliminary proxy
5:49pm
8-K
EX-99.1
hv3k8gjll7gcv bvg
9 Nov 22
Absci Reports Third Quarter 2022 Financial Results
9:18am
8-K
EX-99.1
5mj2z7udev6e3
2 Nov 22
Absci Welcomes Meta Senior Executive to Board of Directors
4:06pm
8-K
EX-99.1
7v82jkd
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
S-3
au8ohj13kvmk 0xgy5
24 Aug 22
Shelf registration
4:07pm
8-K
EX-99.1
62zqtb
11 Aug 22
Absci Reports Second Quarter 2022 Financial Results and Business Update
8:33am
8-K
EX-99.1
3hhd1msnkbgqn
11 May 22
Absci Reports First Quarter 2022 Financial and Operating Results
8:15am
DEF 14A
1v4 gtzmnb
26 Apr 22
Definitive proxy
4:39pm
10-K
v50ia3
22 Mar 22
Annual report
5:20pm
8-K
EX-99.1
er820
22 Mar 22
Absci Reports Full Year 2021 Financial and Operating Results
4:07pm
8-K
EX-99.2
mhp3dkj keltrau8e
22 Mar 22
Absci Reports Full Year 2021 Financial and Operating Results
4:07pm
8-K
EX-99.1
3f7kziai58fx4c413
7 Jan 22
Absci Announces Research Collaboration with Merck
8:53am
8-K
EX-99.1
3x5x5on1l47411bbtrj0
9 Nov 21
Absci Reports Third Quarter 2021 Financial and Operating Results
8:02am